Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)
9,460.00
+50.00 (0.53%)
At close: Jan 23, 2026
KOSDAQ:072020 Revenue
Choong Ang Vaccine Laboratory had revenue of 10.23B KRW in the quarter ending March 31, 2023, a decrease of -1.05%. This brings the company's revenue in the last twelve months to 39.19B, down -4.18% year-over-year. In the year 2022, Choong Ang Vaccine Laboratory had annual revenue of 39.30B, down -3.95%.
Revenue (ttm)
39.19B
Revenue Growth
-4.18%
P/S Ratio
2.30
Revenue / Employee
234.67M
Employees
167
Market Cap
89.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 39.30B | -1.61B | -3.95% |
| Dec 31, 2021 | 40.91B | 4.60B | 12.66% |
| Dec 31, 2020 | 36.32B | 17.05B | 88.53% |
| Dec 31, 2012 | 19.26B | 3.67B | 23.57% |
| Dec 31, 2011 | 15.59B | -507.67M | -3.15% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 132.76B |
| Cell Biotech | 50.65B |
| Naturalendo Tech | 21.87B |
| PanGen Biotech | 15.27B |
| HLB Pep | 4.89B |
| Quratis | 2.28B |
| SunBio,Inc. | 2.17B |
| Progen | 450.00M |